News Release

CME Group Inc. Reports Strong Fourth-Quarter and Full-Year Revenues and Operating Income

Tue Feb 03 2009

CHICAGO, Feb. 3 /PRNewswire-FirstCall/ -- CME Group Inc. today reported that total fourth-quarter GAAP revenues increased 31 percent to $692 million, and GAAP operating income increased 33 percent to $418 million. The company has taken a pre-tax, non-cash impairment charge of $275 million on its cross-equity investment in BM&F Bovespa SA, due to the decline in BM&F Bovespa's current share price relative to original investment value. On a relative equity swap exchange basis, the economic value of CME Group's equity stake in BM&F Bovespa has actually increased since the effective date of the agreement. While management of the company has determined that an impairment charge is appropriate under GAAP standards, management believes BM&F Bovespa's stock price reflects current cyclical factors in the public company exchange sector and continues to present attractive long-term financial and strategic opportunities for CME Group. Additionally, CME Group and BM&F Bovespa are on track with the implementation of reciprocal order routing arrangements to facilitate increased customer transaction flow to their respective trading platforms.

As a result of the impairment charge, GAAP net income for the fourth quarter was $62 million and diluted earnings per share on a GAAP basis were $0.93. In conjunction with this charge, stockholders' equity was reduced by $94 million due to unfavorable movements in the Brazilian real compared with the U.S. dollar. Aside from the BM&F Bovespa impairment charge, the fourth- quarter GAAP results also include $17.5 million of merger-related items. The 2008 GAAP results reflect the operations of both Chicago Mercantile Exchange (CME) and Board of Trade of the City of Chicago (CBOT), as well as the results of New York Mercantile Exchange, Inc. (NYMEX) after August 22, 2008 when the acquisition closed.

Pro forma non-GAAP diluted earnings per share in the fourth quarter were $3.58, the same as the prior year period. All pro forma results reflect the operations of both CME Group Inc. and NYMEX, as if they were combined for all periods reported. Additionally, fourth-quarter 2008 pro forma non-GAAP results exclude the impairment charge related to BM&F Bovespa and the merger- related items listed above. Total revenues increased one percent to $692 million, and the combined average rate per contract increased to 86 cents, up from 75 cents in fourth quarter 2007, primarily due to an increased proportion of higher priced contracts. Pro forma total operating expenses decreased three percent to $258 million, compared with the same period last year. A higher rate per contract and continued focus on expense discipline helped the company reach fourth-quarter operating income of $433 million, an increase of three percent from $419 million for the year-ago period, and operating margin of 63 percent, compared with 61 percent for fourth-quarter 2007. Operating margin is defined as operating income as a percentage of total revenues. Pro forma net income increased one percent to $239 million for fourth-quarter 2008. Pro forma measures do not replace and are not a substitute for GAAP financial results. They are provided to improve overall understanding of current financial performance and to provide a meaningful comparison with prior periods. A full reconciliation of these fourth-quarter and full-year 2008 pro forma results is included with the attached financial statements.

All references to volume and rate per contract information in the text of this document exclude our non-traditional TRAKRS products, for which CME Group receives significantly lower clearing fees than other CME Group products, and Swapstream products.

Full-year 2008 pro forma non-GAAP revenues increased 11 percent to $3.1 billion and operating income increased 20 percent to $2.0 billion compared with 2007. Pro forma operating margin grew to 65 percent in 2008, compared with 60 percent in 2007. Full-year pro forma net income and diluted earnings per share both increased 16 percent, compared with the prior year, to $1.1 billion and $16.17 respectively.

"CME Group's revenue growth at a time of global recession highlights the value of our product diversity -- which includes benchmark contracts in every asset class -- to address customer needs under a variety of market conditions," said CME Group Executive Chairman Terry Duffy. "Given the recent market dislocations, we see opportunities to reach out to non-traditional users of futures products, extend our technology and sales efforts globally and cross-sell our products. While we are aware of the challenges still facing financial markets, we also are confident that our long-term growth prospects are strong and we will continue to execute our strategy to build on the opportunities ahead."

"Despite the very challenging economic and financial market conditions in the fourth quarter, CME Group's overall performance compared favorably with other financial sector leaders," said CME Group Chief Executive Officer Craig Donohue. "We grew revenues, reduced expenses, and increased margins, while making significant progress and remaining on track with synergy achievement in our CBOT and NYMEX integrations. Although dislocations in credit and lending markets have significantly impacted our interest rate complex, our other product lines, especially equity indexes, showed solid volume growth. In addition, the volume of business done on our over-the-counter ClearPort platform increased dramatically as we further expanded the range of products we offer to OTC market participants. Looking forward, we will continue to focus on expense discipline while providing customers with the best ways to manage risk at a time of economic uncertainty."



    CME Group Inc. Fourth-Quarter and Full-Year 2008 Results

    Financial Highlights:

    GAAP

    ($s in millions,
     except per share) Q4 FY08    Q4 FY07   Y/Y     FY08      FY07      Y/Y

    Revenues             $692      $530     31%    $2,561    $1,756     46%
    Expenses             $274      $216     27%      $979      $704     39%
    Operating Income     $418      $313     33%    $1,582    $1,052     50%
    Operating Margin %  60.4%     59.2%             61.8%     59.9%
    Net Income            $62      $201    -69%      $715      $659      9%
    Diluted EPS         $0.93     $3.75    -75%    $12.13    $14.93    -19%



    Pro Forma Non-GAAP

    ($s in millions,
     except per share) Q4 FY08    Q4 FY07    Y/Y    FY08      FY07      Y/Y

    Revenues             $692       $687      1%   $3,051    $2,740     11%
    Expenses             $258       $268     -3%   $1,081    $1,102     -2%
    Operating Income     $433       $419      3%   $1,970    $1,638     20%
    Operating Margin %  62.6%      61.0%            64.6%     59.8%
    Net Income           $239       $236      1%   $1,084      $935     16%
    Diluted EPS         $3.58      $3.58      0%   $16.17    $13.93     16%

NOTE: See the CME Group Inc. Reconciliation of GAAP to Pro Forma Non-GAAP Measures for detail related to the adjustments made to reach the pro forma results.

Pro Forma Non-GAAP Fourth-Quarter 2008 Financial Results

Fourth-quarter 2008 average daily volume of 10.4 million contracts drove $573 million in clearing and transaction fee revenue, down slightly from $583 million in fourth-quarter 2007. Fourth-quarter 2008 quotation data fees were up 17 percent to $87 million. The average rate per contract for CME Group, excluding NYMEX for the entire period, was $0.713 for the quarter, up 10 percent compared with the average rate per contract of $0.648 in fourth- quarter 2007. The total pro forma average gross rate per contract for the NYMEX business was $1.671 for the quarter, up 14 percent compared with $1.471 in fourth-quarter 2007.

Fourth-quarter 2008 pro forma non-operating expense was $30 million, driven primarily by interest expense and borrowing costs of $35 million. Additionally, the fourth-quarter 2008 effective tax rate was 40.7 percent.

As of December 31, the company had $608 million of cash and marketable securities and $3.2 billion of debt. Since the $1.1 billion share buyback program was announced in June, the company has purchased shares with an approximate aggregate value of $250 million. The share buyback authorization remains in place, however the company has stopped purchasing shares in the near-term and is focused on paying down debt.

CME Group will hold a conference call to discuss fourth-quarter and full- year 2008 results at 8:30 a.m. Eastern Time today. A live audio Webcast of the call will be available on the Investor Relations section of CME Group's Web site at http://www.cmegroup.com. An archived recording will be available for up to two months after the call.

CME Group (http://www.cmegroup.com) is the world's largest and most diverse derivatives exchange. Building on the heritage of CME, CBOT and NYMEX, CME Group serves the risk management needs of customers around the globe. As an international marketplace, CME Group brings buyers and sellers together on the CME Globex electronic trading platform and on trading floors in Chicago and New York. By acting as the buyer to every seller and the seller to every buyer, CME Clearing virtually eliminates counterparty credit risk. CME Clearing also offers $8 billion in financial safeguards to help mitigate systemic risk, providing the security and confidence market participants need to operate, invest and grow. CME Group offers the widest range of benchmark products available across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, and alternative investment products such as weather and real estate. CME Group is listed on NASDAQ under the symbol "CME."

The Globe logo, CME, Chicago Mercantile Exchange, CME Group, Globex, E- mini and CME ClearPort are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago. NYMEX and New York Mercantile Exchange are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All other trademarks are the property of their respective owners. Further information about CME Group and its products can be found at http://www.cmegroup.com.

Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. Among the factors that might affect our performance are: our ability to realize the benefits and control the costs of our merger with NYMEX Holdings, Inc. and our ability to successfully integrate the businesses of CME Group and NYMEX Holdings, including the fact that such integration may be more difficult, time consuming or costly than expected and revenues following the merger may be lower than expected and expected cost savings from the merger may not be fully realized within the expected time frames or at all; increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development and implementation of the enhanced functionality required by our customers; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to generate future revenues from processing services; our ability to maintain existing customers and attract new ones; our ability to expand and offer our products in foreign jurisdictions; changes in domestic and foreign regulations; changes in government policy, including policies relating to common or directed clearing, changes as a result of a combination of the Securities and Exchange Commission and the Commodity Futures Trading Commission, or changes relating to the recently enacted Emergency Economic Stabilization Act of 2008; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; our ability to generate revenue from our market data that may be reduced or eliminated by decreased demand or the growth of electronic trading or declines in subscriptions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our financial safeguards package to adequately protect us from the credit risks of clearing members; the ability of our compliance and risk management methods to effectively monitor and manage our risks; changes in price levels and volatility in the derivatives markets and in underlying fixed income, equity, foreign exchange and commodities markets; economic, political, geopolitical and market conditions, including the recent volatility of the capital and credit markets; natural disasters and other catastrophes, our ability to accommodate increases in trading volume and order transaction traffic without failure or degradation of performance of our systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks and control the costs associated with our acquisition, investment and alliance strategy; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a transaction tax on futures and options on futures transactions; the unfavorable resolution of material legal proceedings, the seasonality of the futures business; and changes in the regulation of our industry with respect to speculative trading in commodity interests and derivatives contracts. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, including our most recent periodic reports filed on Form 10-K and Form 10-Q and our Current Report on Form 8-K, filed on October 29, 2008, which are available in the Investor Relations section of the CME Group Web site. We undertake no obligation to publicly update any forward- looking statements, whether as a result of new information, future events or otherwise.


CME-E



                       CME Group Inc. and Subsidiaries
                         Consolidated Balance Sheets
                            (dollars in thousands)

                                                 December 31,     December 31,
                                                     2008             2007
    ASSETS
    Current Assets:
         Cash and cash equivalents                $297,895          $845,312
         Collateral from securities lending        426,958         2,862,026
         Marketable securities, including
          pledged securities                       310,077           203,308
         Accounts receivable, net of allowance     234,001           187,487
         Other current assets                      170,122            55,900
         Cash performance bonds and security
          deposits                              17,653,513           833,022
    Total current assets                        19,092,566         4,987,055
    Property, net of accumulated depreciation
     and amortization                              707,215           377,452
    Intangible assets - trading products        16,982,000         7,987,000
    Intangible assets - other, net of
     accumulated amortization                    3,370,961         1,796,789
    Goodwill                                     7,502,805         5,049,211
    Other assets                                   477,265           108,690
    Total Assets                               $48,132,812       $20,306,197

    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current Liabilities:
         Accounts payable                          $71,012           $58,965
         Payable under securities lending
          agreements                               456,833         2,862,026
         Short-term debt                           802,900           164,435
         Other current liabilities                 184,337           157,615
         Cash performance bonds and security
          deposits                              17,653,513           833,022
    Total current liabilities                   19,168,595         4,076,063
    Long-term debt                               2,413,029                 -
    Deferred tax liabilities                     7,728,286         3,848,240
    Other liabilities                              134,333            76,257
    Total Liabilities                           29,444,243         8,000,560
    Shareholders' equity                        18,688,569        12,305,637
    Total Liabilities and Shareholders'
     Equity                                    $48,132,812       $20,306,197



                       CME Group Inc. and Subsidiaries
                      Consolidated Statements of Income
                   (in thousands, except per share amounts)

                                     Quarter Ended           Year Ended
                                      December 31,          December 31,
                                     2008      2007       2008        2007
    Revenues
         Clearing and
          transaction fees         $573,086  $438,517  $2,115,366  $1,427,320
         Quotation data fees         87,252    49,891     279,533     145,054
         Processing services            129    16,104      54,073     106,404
         Access and communication
          fees                       11,424    10,649      43,618      36,511
         Other                       19,878    14,378      68,429      40,812
         Total Revenues             691,769   529,539   2,561,019   1,756,101

    Expenses
         Compensation and
          benefits                   86,096    71,756     317,554     263,347
         Communications              13,221    13,498      52,339      43,471
         Technology support
          services                   12,570    17,196      59,611      50,480
         Professional fees
          and outside
          services                   24,161    16,814      71,944      53,142
         Amortization of
          purchased
          intangibles                35,524    17,286      98,682      33,878
         Depreciation and
          amortization               34,472    32,992     137,341     105,653
         Occupancy and
          building
          operations                 18,484    15,368      71,388      48,203
         Licensing and other
          fee agreements             25,467    10,351      70,259      35,651
         Restructuring                2,774     4,380       4,839       8,892
         Other                       21,145    16,551      94,867      61,476
         Total Expenses             273,914   216,192     978,824     704,193

    Operating Income                417,855   313,347   1,582,195   1,051,908

    Non-Operating Income and
     Expense
         Investment income            4,105    15,430      45,514      73,157
         Impairment of long-
          term investment          (274,507)             (274,507)
         Gains (losses) on
          derivative
          investments                  (390)     (158)     (8,148)        (98)
         Securities lending
          interest income             6,176    29,934      38,323     121,494
         Securities lending
          interest and other
          costs                      (3,511)  (27,067)    (51,722)   (115,868)
         Interest and other
          borrowing costs           (34,911)   (2,185)    (56,501)     (3,629)
         Guarantee of
          exercise right
          privileges                     35    11,332      12,824     (17,167)
         Equity in losses of
          unconsolidated
          subsidiaries               (3,629)   (3,941)    (31,556)    (13,995)
         Other non-operating
          expense                       (60)        -      (8,458)          -
         Total Non-Operating       (306,692)   23,345    (334,231)     43,894

    Income Before Income
     Taxes                          111,163   336,692   1,247,964   1,095,802

    Income tax provision            (49,098) (135,634)   (532,478)   (437,269)
    Net Income                      $62,065  $201,058    $715,486    $658,533

    Earnings per Common
     Share:
         Basic                        $0.93     $3.78      $12.18      $15.05
         Diluted                      $0.93     $3.75      $12.13      $14.93
    Weighted Average Number
     of Common Shares:
         Basic                       66,731    53,245      58,738      43,754
         Diluted                     66,904    53,564      58,967      44,107



                       CME Group Inc. and Subsidiaries
             Pro Forma Non-GAAP Consolidated Statements of Income
                   (in thousands, except per share amounts)

                                     Quarter Ended           Year Ended
                                      December 31,          December 31,
                                     2008      2007       2008        2007
    Revenues
         Clearing and transaction
          fees                     $573,086  $583,447  $2,581,255  $2,332,636
         Quotation data fees         87,252    74,449     348,631     293,495
         Processing services            129       672       1,748       2,174
         Access and communication
          fees                       11,424    10,885      44,389      40,750
         Other                       19,878    17,235      75,470      71,304
         Total Revenues             691,769   686,688   3,051,493   2,740,359

    Expenses
         Compensation and benefits   83,443    92,436     356,427     388,377
         Communications              13,221    14,774      55,576      57,210
         Technology support
          services                   12,570    19,448      65,245      75,430
         Professional fees and
          outside services           20,159    18,770      76,403      71,596
         Amortization of purchased
          intangibles                30,523    30,805     122,993     122,836
         Depreciation and
          amortization               34,472    34,161     139,931     142,476
         Occupancy and building
          operations                 18,484    19,483      82,303      75,252
         Licensing and other fee
          agreements                 25,467    18,634      96,110      83,081
         Other                       20,135    19,218      86,357      86,056
         Total Expenses             258,474   267,729   1,081,345   1,102,314

    Operating Income                433,295   418,959   1,970,148   1,638,045

    Non-Operating Income and Expense
         Investment income            4,105    21,224      54,312     106,857
         Gains (losses) on
          derivative investments       (390)     (158)       (261)        (98)
         Securities lending
          interest income             6,176    41,394      52,925     213,402
         Securities lending
          interest and other costs     (971)  (37,449)    (45,653)   (204,112)
         Interest and other
          borrowing costs           (34,911)  (38,081)   (149,154)   (152,324)
         Equity in losses of
          unconsolidated
          subsidiaries               (3,717)   (6,705)    (20,929)    (24,174)
         Total Non-Operating        (29,708)  (19,775)   (108,760)    (60,449)

    Income Before Income Taxes      403,587   399,184   1,861,388   1,577,596

    Income tax provision           (164,102) (162,780)   (777,760)   (642,125)
    Net Income                     $239,485  $236,404  $1,083,628    $935,471

    Earnings per Diluted Common
     Share                            $3.58     $3.58      $16.17      $13.93

    Weighted Average Number of
     Diluted Common Shares*          66,904    66,104      67,022      67,139

    Note:  All pro forma results for CME Group assume the merger with CBOT and
           the acquisition of NYMEX were completed as of the beginning of the
           period presented.  Pro Forma Non-GAAP results exclude the
           impairment charge related to BM&F.  See CME Group Inc.
           Reconciliation of GAAP to Pro Forma Non-GAAP Measures for detail on
           all of the adjustments made to reach the pro forma results.

    * Weighted average number of diluted common shares includes merger-related
      shares converted or issued for the entire period reported.



                       CME Group Inc. and Subsidiaries
            Reconciliation of GAAP to Pro Forma Non-GAAP Measures
                                (in thousands)

                                     Quarter Ended           Year Ended
                                      December 31,          December 31,
                                     2008      2007       2008        2007
    GAAP Results
    Revenues                       $691,769  $529,539  $2,561,019  $1,756,101
    Expenses                        273,914   216,192     978,824     704,193
    Operating income                417,855   313,347   1,582,195   1,051,908

    Non-operating income and
     expense                       (306,692)   23,345    (334,231)     43,894
    Income before income taxes      111,163   336,692   1,247,964   1,095,802
    Income tax provision            (49,098) (135,634)   (532,478)   (437,269)
         Net Income                 $62,065  $201,058    $715,486    $658,533


    Pro Forma Adjustments
    Revenues:
    CBOT pre-merger revenue              $-        $-          $-    $414,881
    NYMEX pre-merger revenue              -   172,581     543,949     673,607
    Intercompany revenue
     elimination(1)                       -   (15,432)    (45,724)   (104,230)
    FXMarketSpace write down              -                (7,751)          -
    Total Pro Forma Revenue Adjustment    -   157,149     490,474     984,258

    Expenses:
    CBOT pre-merger expense               -         -           -     219,296
    NYMEX pre-merger expense              -    64,461     229,242     264,422
    Intercompany expense
     elimination (1)                      -   (15,432)    (45,724)   (104,230)
    Amortization of intangibles (2)  (5,001)   13,518      27,588      88,897
    Depreciation adjustment from
     building life change (3)             -     1,476       3,923       5,904
    Swapstream writeoff                   -         -     (14,315)          -
    Loss on sale of metals               22         -      (2,758)          -
    FXMS writeoff                         -         -      (2,616)          -
    Other (4)                       (10,461)  (12,486)    (92,819)    (76,168)
    Total Pro Forma Expense
     Adjustment                     (15,440)   51,537     102,521     398,121

    Adjustment to operating income   15,440   105,612     387,953     586,137

    Non-operating income and expense:
    CBOT premerger non-operating
     income                               -         -           -      13,146
    NYMEX premerger non-operating
     income                               -     2,522      32,425     (14,403)
    Interest on debt acquired for
     NYMEX deal                           -   (34,310)    (88,576)   (146,215)
    Equity investment unusual gain
     or loss(5)                           -         -     (14,699)     25,962
    Securities lending writedown      2,540         -      18,286           -
    ERP Guarantee (6)                   (35)  (11,332)    (12,824)     17,167
    BM&F Bovespa (7)                274,479         -     290,859           -
    Total Pro Forma Non-Operating
     Income and Expense Adjustment  276,984   (43,120)    225,471    (104,343)
    Adjustment to income before
     income taxes                   292,424    62,492     613,424     481,794
    Adjustment to income tax
     provision                     (115,004)  (27,146)   (245,282)   (204,856)
         Adjustment to net income  $177,420   $35,346    $368,142    $276,938


    Pro Forma Non-GAAP Results
    Revenues                       $691,769  $686,688  $3,051,493  $2,740,359
    Expenses                        258,474   267,729   1,081,345   1,102,314
    Operating income                433,295   418,959   1,970,148   1,638,045

    Non-operating income and
     expense                        (29,708)  (19,775)   (108,760)    (60,449)
    Income before income taxes      403,587   399,184   1,861,388   1,577,596
    Income tax provision (8)       (164,102) (162,780)   (777,760)   (642,125)
         Net Income                $239,485  $236,404  $1,083,628    $935,471

    Notes:
    (1)  Eliminate clearing services provided to CBOT prior to the merger and
         processing services provided prior to the NYMEX acquisition.
    (2)  Add amortization of intangible assets recorded in purchase of CBOT
         and NYMEX.
    (3)  Adjust depreciation for changes in value and useful life of building
         acquired from NYMEX.
    (4)  Reverse effect of restructuring, accelerated depreciation,
         integration and legal expenses related to the merger with CBOT and
         acquisition of NYMEX.  Also removes other merger-related transaction
         costs that were expensed and transaction costs related to the
         acquisition of CMA.
    (5)  Write-down of FXMarketSpace and Optionable as well as a gain related
         to TSX Group.
    (6)  Reverse impact of exercise right privilege guarantee.
    (7)  Reverse transaction costs related to the BM&F/Bovespa investment,
         including a pre-tax impairment charge of that investment in Q4 2008.
    (8)  Pro forma adjustments through September 30, 2008 are tax affected at
         41.5%, the mid point of CME Group's estimated effective tax rate. Pro
         forma adjustments in the fourth quarter 2008 related to BM&F Bovespa
         are based on the tax benefit recorded.  Also, a first quarter 2008
         tax benefit of $38.6 million due to a change in Illinois state tax
         treatment for apportionment of revenues sourced within the state has
         been removed for proforma purposes. Finally, a third quarter 2008
         non-cash tax expense of $48.3 million due to adjusting deferred taxes
         related to the NYMEX acquisition has also been removed for proforma
         purposes.



                                CME Group Inc.
                        Quarterly Operating Statistics

                  4Q 2007       1Q 2008      2Q 2008      3Q 2008     4Q 2008

    Trading Days       64           61           64          64          64


                     Quarterly Average Daily Volume (ADV)

       CME Group Pro Forma ADV (Legacy CME, CBOT and NYMEX combined, in
                                  thousands)


                  4Q 2007       1Q 2008      2Q 2008    3Q 2008     4Q 2008

    Total          12,113       15,540       12,876      13,236      10,441


  CME Group ADV (Legacy CME and CBOT combined for periods prior to 4Q07, in
                                  thousands)


                  4Q 2007       1Q 2008      2Q 2008    3Q 2008     4Q 2008
    Product Line
    Interest rates  6,290        8,251        6,467       6,030       3,692
    Equity E-mini   2,817        3,628        2,833       3,638       3,799
    Equity standard-
     size             166          201          161         204         194
    Foreign exchange  561          640          665         710         481
    Commodities &
     alternative
     investments      740          949          933         822         691
      Total        10,574       13,669       11,060      11,404       8,857

    Venue
    Open outcry     1,876        2,336        1,836       1,602       1,275
    Electronic
     (excluding
     TRAKRS)        8,528       11,097        9,054       9,641       7,447
    Privately
     negotiated       169          236          170         161         136
      Total        10,574       13,669       11,060      11,404       8,857


                        NYMEX/COMEX ADV (in thousands)


                  4Q 2007       1Q 2008      2Q 2008     3Q 2008     4Q 2008

    NYMEX floor       229          257          238         193         166
    NYMEX electronic  704          814          865         831         682
    COMEX floor        42           47           38          36          29
    COMEX electronic  147          205          172         214         144
    NYMEX ClearPort   310          473          418         492         489
    Other             107           75           85          65          75
      Total         1,539        1,870        1,816       1,831       1,584


                       Average Rate Per Contract (RPC)

    CME Group Pro Forma Average RPC (Legacy CME, CBOT and NYMEX combined)


                  4Q 2007       1Q 2008      2Q 2008    3Q 2008     4Q 2008

    Total          $0.753       $0.743       $0.775      $0.785     $0.858


   CME Group RPC (Legacy CME and CBOT combined for entire periods reported)


                  4Q 2007       1Q 2008      2Q 2008    3Q 2008     4Q 2008
    Product Line
    Interest rates $0.530       $0.505       $0.522      $0.521     $0.569
    Equity E-mini   0.687        0.684        0.668       0.677      0.706
    Equity standard-
     size           1.427        1.506        1.453       1.486      1.582
    Foreign
     exchange       0.985        0.927        0.907       0.936      0.894
    Commodities &
     alternative
     investments    1.074        1.119        1.134       1.154      1.154
      Average RPC
       (excluding
       TRAKRS)     $0.648       $0.630       $0.648      $0.659     $0.713

    Venue
    Open outcry    $0.517       $0.553       $0.572      $0.607     $0.663
    Electronic
     (excluding
     TRAKRS)        0.629        0.609        0.629       0.637      0.691
    Privately
     negotiated     3.057        2.345        2.427       2.526      2.558


                               NYMEX/COMEX RPC


                  4Q 2007       1Q 2008      2Q 2008    3Q 2008     4Q 2008

    NYMEX floor    $1.470       $1.594       $1.607      $1.386     $1.600
    NYMEX
     electronic     1.204        1.324        1.304       1.315      1.308
    COMEX floor     1.466        1.641        1.712       1.626      1.801
    COMEX
     electronic     1.549        1.630        1.706       1.719      1.781
    NYMEX ClearPort 1.925        1.875        1.905       0.933      2.099
    Other           1.809        1.923        1.854       1.928      2.038
      Total Pro
       Forma
       Average
       Gross Rate  $1.471       $1.570       $1.556      $1.567     $1.671

      Total Pro
       Forma Average
       Net Rate    $1.388       $1.472       $1.479      $1.488     $1.569

    Note:  All CME Group volume and rate per contract data is based upon pro
           forma results, including the operations of CME Group and NYMEX as
           if they were combined for the entire period reported.  All data
           excludes our non-traditional TRAKRS products, for which CME Group
           receives significantly lower clearing fees than other CME Group
           products.  Additionally, all data excludes Swapstream products.

SOURCE: CME Group Inc.

Web site: http://www.cmegroup.com/

Corporate Communications

+1 312 930 3434
Email